AiVita Biomedical
PrivateLast Round
Series B
Extension
Dec 29, 2020
Total Funding Raised
$60.5M
Company Overview
AiVita Biomedical is a biotechnology company that develops personalized vaccines for infectious diseases and cancer treatment, as well as innovative vaccine kits for pathogen readiness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AiVita Biomedical Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
AiVita Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 29, 2020 | ||||
| Series B | Feb 25, 2020 | ||||
| Grant | Jul 17, 2018 | ||||
| Series B | Jun 11, 2018 | ||||
| Grant | Sep 29, 2016 | ||||
Grant | Jul 7, 2016 |
Key People
Founding team and executive leadership
AiVita Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Eye Institute (NIH) | Grant |
| NIH RADx | Grant |
| California Technology Ventures | Series A |
| California Institute for Regenerative Medicine | Grant |
| National Eye Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2016
$300K grant from the National Eye Institute (NIH).
AiVita Biomedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AiVita Biomedical's valuation, stock price, and market status.